SAVA

Cassava Sciences, Inc. SAVA

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SAVA AVXL ANVS IOVA AXSM NVAX OCGN VXRT BNGO
6M 222.83 % -2.71 % 27.69 % -35.15 % 23.55 % 47.10 % 131.75 % -4.55 % -56.64 %
YTD 49.09 % -29.05 % -67.51 % -72.53 % 38.74 % 0.58 % 77.78 % -52.69 % -87.21 %
1Y 4.33 % 59.33 % -77.90 % -78.10 % 41.83 % -31.70 % 68.44 % -56.07 % -90.67 %
3Y -22.93 % -21.42 % -86.86 % -76.59 % 162.17 % -59.49 % -6.43 % -81.42 % -99.86 %
5Y 156.25 % 93.27 % -66.73 % -93.40 % 60.27 % -92.65 % 383.38 % -95.57 % -99.45 %
10Y 106.03 % -3.36 % -82.69 % -64.45 % 1 286.16 % -94.34 % -99.40 % -98.52 % -96.81 %
From the beginning -81.26 % 7.75 % -82.69 % -98.05 % 1 286.16 % -89.23 % -99.77 % -99.71 % -96.81 %

Dividend

Cassava Sciences, Inc.

Vaxart, Inc.